You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nascent geographic atrophy

Showing 1 - 25 of 1,662
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-Related Macular Degeneration Trial in East Melbourne (2RT subthreshold nanosecond laser)

Recruiting
  • Age-Related Macular Degeneration
  • 2RT subthreshold nanosecond laser
  • East Melbourne, Victoria, Australia
    Centre for Eye Research Australia
Jan 16, 2022

Macular Degeneration, Age Related, Geographic Atrophy Trial in Madison (Spectralis FAF imaging, Optos imaging, Zeiss Clarus 700

Not yet recruiting
  • Macular Degeneration, Age Related
  • Geographic Atrophy
  • Spectralis FAF imaging
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Jul 18, 2023

Geographic Atrophy and Their Patient Journey in United States

Not yet recruiting
  • Geographic Atrophy
    • (no location specified)
    May 26, 2023

    Geographic Atrophy Trial in Bellaire, Dallas (OCU410)

    Recruiting
    • Geographic Atrophy
    • OCU410
    • Bellaire, Texas
    • +1 more
    Aug 25, 2023

    Optical Coherence Tomography and Microperimetry Biomarker

    Active, not recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • Natural history study
    • Basel, Basel-Stadt, Switzerland
      University Hospital Basel
    Jul 19, 2023

    Geographic Atrophy Trial (BI 771716)

    Not yet recruiting
    • Geographic Atrophy
    • BI 771716
    • (no location specified)
    Aug 29, 2023

    Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)

    Not yet recruiting
    • Geographic Atrophy of the Macula
    • Macular Degeneration
    • Saint Petersburg, Florida
    • +4 more
    Apr 20, 2023

    Geographic Atrophy Trial in Huntington Beach, Hagerstown (Tinlarebant, Placebo)

    Recruiting
    • Geographic Atrophy
    • Huntington Beach, California
    • +1 more
    Jul 21, 2023

    Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

    Recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Phoenix, Arizona
    • +3 more
    Mar 31, 2023

    Geographic Atrophy Trial (FCFD4514S)

    Completed
    • Geographic Atrophy
    • (no location specified)
    Dec 9, 2022

    Geographic Atrophy Trial in Cincinnati (OpRegen)

    Recruiting
    • Geographic Atrophy
    • OpRegen
    • Cincinnati, Ohio
      Cincinnati Eye Institute
    Jan 12, 2023

    Geographic Atrophy Insights (i-GAIN) Natural History Study

    Recruiting
    • Dry Age-related Macular Degeneration
    • +6 more
      • Belfast, United Kingdom
      • +11 more
      Mar 22, 2023

      Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)

      Not yet recruiting
      • Age-Related Macular Degeneration
      • Active Comparator CT1812
      • Placebo Comparator
      • (no location specified)
      Jun 5, 2023

      Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)

      Recruiting
      • Age-Related Macular Degeneration
      • iPSC-derived RPE/PLGA transplantation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)

      Recruiting
      • Age-related Macular Degeneration (AMD)
      • Dimethyl Fumarate (TECFIDERA™)
      • No active : no treatment
      • Créteil, Val De Marne, France
        Centre intercommunal de Créteil
      Aug 2, 2022

      Geographic Atrophy, Age-Related Macular Degeneration Trial in Barcelona (postbiotics (IGENH35.3A), vitamins (AREDS formulation

      Active, not recruiting
      • Geographic Atrophy
      • Age-Related Macular Degeneration
      • postbiotics (IGENH35.3A)
      • vitamins (AREDS formulation and recommended daily dose)
      • Barcelona, Spain
        Institut de la Màcula
      Jun 18, 2022

      Age-Related Macular Degeneration Trial run by the NEI (Minocycline)

      Active, not recruiting
      • Age-Related Macular Degeneration
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 22, 2022

      Geographic Atrophy Associated With Age-Related Macular

      Recruiting
      • Age-Related Macular Degeneration
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 21, 2022

        Geographic Atrophy Trial in United States (RO7303359)

        Active, not recruiting
        • Geographic Atrophy
        • Encino, California
        • +12 more
        Dec 12, 2022

        Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) Trial (EG-301, AREDS2 supplements)

        Not yet recruiting
        • Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
        • (no location specified)
        Jul 27, 2022

        ORACLE: A Long-term Follow-up Study to Evaluate Safety and

        Enrolling by invitation
        • Age Related Macular Degeneration (AMD)
        • GT005
        • Reno, Nevada
          Sierra Eye Associates
        Aug 9, 2022

        Geographic Atrophy, Age Related Macular Degeneration, AMD Trial in Somerville (ALK-001 oral capsule, Placebo oral capsule)

        Active, not recruiting
        • Geographic Atrophy
        • +3 more
        • ALK-001 oral capsule
        • Placebo oral capsule
        • Somerville, Massachusetts
          Coordinating Center
        Feb 15, 2022

        Macular Degeneration Trial in United Kingdom, United States (BI 754132)

        Terminated
        • Macular Degeneration
        • BI 754132
        • Beverly Hills, California
        • +12 more
        Aug 23, 2022

        Age-Related Macular Degeneration, Geographic Atrophy Trial in Holon (smaller incision, new generation implantable miniature

        Not yet recruiting
        • Age-Related Macular Degeneration
        • Geographic Atrophy
        • smaller incision, new generation implantable miniature telescope (SING-IMT)
        • Holon, Tel Aviv, Israel
          Wolfson Medical Center
        Jul 3, 2023

        Geographic Atrophy Trial in United States (PEGCETACOPLAN (APL-2))

        Completed
        • Geographic Atrophy
        • PEGCETACOPLAN (APL-2)
        • Bakersfield, California
        • +4 more
        Nov 8, 2021